We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+4.57%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$280M
AUM Growth
+$2.67M
Cap. Flow
-$6.97M
Cap. Flow %
-2.49%
Top 10 Hldgs %
26.24%
Holding
526
New
387
Increased
35
Reduced
72
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 25.94%
2 Financials 16.28%
3 Industrials 14.09%
4 Healthcare 13.41%
5 Communication Services 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VVV icon
376
Valvoline
VVV
$4.49B
$2K ﹤0.01%
+74
New +$1.66K
WDC icon
377
Western Digital
WDC
$149B
$2K ﹤0.01%
+37
New +$2.46K
XRX icon
378
Xerox
XRX
$428M
$2K ﹤0.01%
+67
New +$2.11K
QVCGA
379
DELISTED
QVC Group Inc Series A
QVCGA
$2K ﹤0.01%
+2
New +$2.24K
MRO
380
DELISTED
Marathon Oil Corporation
MRO
$2K ﹤0.01%
+172
New +$2.04K
KAMN
381
DELISTED
Kaman Corp
KAMN
$2K ﹤0.01%
+39
New +$1.97K
CTXS
382
DELISTED
Citrix Systems Inc
CTXS
$2K ﹤0.01%
+28
New +$2.17K
CTB
383
DELISTED
Cooper Tire & Rubber Co.
CTB
$2K ﹤0.01%
+42
New +$1.49K
CBM
384
DELISTED
Cambrex Corporation
CBM
$2K ﹤0.01%
+31
New +$1.71K
MDSO
385
DELISTED
Medidata Solutions, Inc.
MDSO
$2K ﹤0.01%
+21
New +$1.6K
USG
386
DELISTED
Usg
USG
$2K ﹤0.01%
+69
New +$1.99K
DST
387
DELISTED
DST Systems Inc.
DST
$2K ﹤0.01%
+32
New +$1.75K
ACAD icon
388
Acadia Pharmaceuticals
ACAD
$4.98B
$1K ﹤0.01%
+16
New +$521
AGX icon
389
Argan
AGX
$8.38B
$1K ﹤0.01%
+13
New +$816
AMCX icon
390
AMC Global Media
AMCX
$487M
$1K ﹤0.01%
+15
New +$893
AMN icon
391
AMN Healthcare
AMN
$1.36B
$1K ﹤0.01%
+22
New +$841
APAM icon
392
Artisan Partners
APAM
$3.02B
$1K ﹤0.01%
+28
New +$870
ASIX icon
393
AdvanSix
ASIX
$439M
$1K ﹤0.01%
+22
New +$746
AVNT icon
394
Avient
AVNT
$4.17B
$1K ﹤0.01%
+18
New +$671
BDX icon
395
Becton Dickinson
BDX
$48.4B
$1K ﹤0.01%
+3
New +$582
BRKR icon
396
Bruker
BRKR
$8.08B
$1K ﹤0.01%
+30
New +$864
BSX icon
397
Boston Scientific
BSX
$71.8B
$1K ﹤0.01%
+22
New +$608
COF icon
398
Capital One
COF
$133B
$1K ﹤0.01%
+15
New +$1.24K
CRL icon
399
Charles River Laboratories
CRL
$12.5B
$1K ﹤0.01%
+13
New +$1.34K
CRUS icon
400
Cirrus Logic
CRUS
$6.21B
$1K ﹤0.01%
+20
New +$1.17K

Similar funds

Contravisory Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Contravisory Investment Management held 526 positions worth $280M, up 0.96% from $278M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Contravisory Investment Management's Q3 2017 filing shows 387 new, 35 increased, 72 reduced and 22 closed positions. Its largest new stake was Westlake Corp: 67,847 shares worth $5.64M. The largest sale was Wabtec, an estimated $5.6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.

  • Contravisory Investment Management's largest Q3 2017 buy was Westlake Corp: 67,847 shares worth $5.64M.
  • Contravisory Investment Management added most to Tiffany & Co. in Q3 2017, an estimated $4.34M increase.
  • Contravisory Investment Management's biggest Q3 2017 reduction was Seagate, cutting an estimated $3.6M.
  • Contravisory Investment Management fully exited Wabtec in Q3 2017, selling an estimated $5.6M.
  • Contravisory Investment Management's ten largest holdings make up 26% of its $280M portfolio in Q3 2017.
  • Contravisory Investment Management opened 387 new positions and closed 22 in Q3 2017.
  • Contravisory Investment Management's portfolio value rose 0.96% quarter-over-quarter to $280M.

Based on Contravisory Investment Management's 13F filing for Q3 2017, filed 12 Oct 2017.